Copenhagen - Delayed Quote • DKK
Novo Nordisk A/S (NOVO-B.CO)
At close: May 17 at 4:59 PM GMT+2
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 23 | 23 |
| Avg. Estimate | 5.38 | 5.99 | 23.39 | 28.66 |
| Low Estimate | 4.93 | 5.53 | 22 | 24.65 |
| High Estimate | 5.85 | 6.4 | 25 | 32.69 |
| Year Ago EPS | 4.31 | 5 | 18.62 | 23.39 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 23 | 23 |
| Avg. Estimate | 66.94B | 71.98B | 290.02B | 350.27B |
| Low Estimate | 64.35B | 66.95B | 272.69B | 310.09B |
| High Estimate | 69.19B | 77.17B | 302.65B | 398.18B |
| Year Ago Sales | 54.3B | 57.16B | 232.26B | 290.02B |
| Sales Growth (year/est) | 23.30% | 25.90% | 24.90% | 20.80% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 4.58 | 4.64 | 4.53 | 5.23 |
| EPS Actual | 4.31 | 5 | 4.91 | 5.68 |
| Difference | -0.27 | 0.36 | 0.38 | 0.45 |
| Surprise % | -5.90% | 7.80% | 8.40% | 8.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 5.38 | 5.99 | 23.39 | 28.66 |
| 7 Days Ago | 5.35 | 5.97 | 23.42 | 28.56 |
| 30 Days Ago | 5.4 | 5.98 | 23.5 | 28.58 |
| 60 Days Ago | 5.41 | 6.01 | 23.48 | 28.61 |
| 90 Days Ago | 5.48 | 6.09 | 22.84 | 27.64 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | 4 |
| Up Last 30 Days | 1 | 2 | 9 | 13 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | NOVO-B.CO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 24.80% | -- | -- | 8.00% |
| Next Qtr. | 19.80% | -- | -- | 12.40% |
| Current Year | 25.60% | -- | -- | 5.60% |
| Next Year | 22.50% | -- | -- | 13.00% |
| Next 5 Years (per annum) | 19.32% | -- | -- | 11.14% |
| Past 5 Years (per annum) | 21.40% | -- | -- | -- |
Research Analysis
Related Tickers
BAVA.CO Bavarian Nordic A/S
178.75
+3.12%
ZEAL.CO Zealand Pharma A/S
600.00
-2.99%
GMAB.CO Genmab A/S
2,041.00
+0.74%
ALK-B.CO ALK-Abelló A/S
152.00
-2.50%
GUBRA.CO Gubra A/S
302.00
+1.00%
VKTX Viking Therapeutics, Inc.
67.00
-2.98%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
1.4080
-0.98%
GMAB Genmab A/S
29.98
+1.11%
HNSA.ST Hansa Biopharma AB (publ)
36.50
-3.03%
ACIU AC Immune SA
3.1800
-6.74%